Regulatory Capture by Pharma Has Created a Bear Trap and a Massive Drag on Global GDP: Predictions for the April 2023 Stock Dump, Why the Pfizer Rummage Sale will Fail, and Beyond

Investments into destructive, chaos-inducing COVID-19 vaccine makers' "pump and dump" schemes are better leveraged for diverse, longer-term financial gains. #DownfallOfTheRegulatoryState

Motley Fool reports that due to being down -14.5%, Pfizer might be a “screaming buy”.

Beware the call of the wild. There are bear traps out there, and they are about to spring. Don’t get stuck holding the bag.

Here are my speculative predictions:

Everyone knows the long-term demographic trends of baby boomers aging means, for the next decade or more, a continuous increase in market size for Pharma and OTC remedies. Finding out that you’ve been had by pump and dump schemes by vaccine makers in the coming April stock dump, however, means you have lost more than 200% of your investment potential. Watch the CEO sell-off starting maybe in February, certainly in March and May after the boom bubble bust. Record amounts of monies are about to trade hands. After or around May, CEOs will jump ship completely. All the signs are there, but I said it first.

Like big tech and financial services regulatory capture are creating a drag, the seemingly sporadic varying values of the two major COVID-19 vaccine makers in the US (Pfizer and Moderna) are all gyrations around a bubble. As the European countries pull back from COVID-19 vaccines due to #PathogenicPriming and #ADE, and even US President Joe Biden has announced a planned end to the emergency, speculation on just how big the Pharma bubble will be is leaving investors skittish about their long-term.

The drag on global GDP due to market manipulations by #Pharma, however, involving the publication of study results by press release, and FDA’s lock-step approval and low-to-no-bar regulation allowed repeated pump and dump events. It also, of course, created a massive drag on global GDP for other opportunities. The vaccine makers are now negotiating prices with the US Federal Government - not a good sign, the party’s over. Even Motley Fool says, specifically,

• “Most U.S.-based pharma stocks enjoyed a strong 2022, as investors sought out reliable safe havens for their capital.

• Pfizer stock, however, wasn't invited to the party, thanks to concerns over its declining earnings potential.”

While these are facts, I do not agree with their rummage sale pitch of “maybe buy” for Pfizer stock.

Why? Because Pfizer and Moderna are about to undergo the fate of BAE and Enron, with backers in high places, necessary for their survival, cutting ties. Why? The massive, undeniable population effects of increased all-cause death and long-term morbidity of the COVID-19 vaccination program will no doubt lead to a catastrophic implosion of the regulatory state, meaning wholesale restructuring of the rules of the game. If this is new to you, sorry about the cold-water treatment. I just thought everyone knew.

Here’s what a savvy investor should know about 2023 and onward:

1. Elected politicians will have to stop trading and trading in actional investment intelligence. (2025+)

2. Election financing reform will once again cap corporate donations to less than $1,000. (2024+)

3. Insider trading will lead to local prosecutions (the evidence was published in headlines in MSM news throughout 2020 and 2021). (late 2023/early 2024)

4. Medical board oversight by elected legislative bodies is coming; Governor oversight fails to protect ethical medical practices that go against those that are merely those which are most profitable. (Staggered, 2023-2026)

5. The revolving doors at FDA and CDC will be slammed shut, (2024+)

6. Freedom from liability will be lost for vaccines, (2024-2025).

If you traded in Moderna and Pfizer, and are still in, don’t be caught holding the bag. Move toward diversified sectors of slow growth.

NB, these are speculative statements and are not meant to be taken as investment advice. Consult with an investment advisor about the safety of your funds and whether riding high during the orchestrated “soft landing” that will likely fall below the radar of detection in trends analyses during the Q1/Q2 switch will leave you holding the bag.

If I had money tied up in Moderna and Pfizer (which I do not), I’d get out now (Feb 1, 2023, no later than May 1, 2023), and would run as far away from them as I could possibly go.

#DownfallOfTheRegulatoryState